RESINTOX v4.2 TAXA-BIO

Vipera berus Clinical & Toxinological Database

Official Resintox Bio-Data Matrix

The European Adder (Vipera berus)

Comprehensive clinical database on venom composition, solenoglyphous fang mechanics, physiological impact, envenomation grading scales, and evidence-based medical treatment guidelines.

LD50 (Mice, IP)
0.55 - 0.80 mg/kg
Max Dry Venom Yield
10 - 18 mg
Fang Type
Solenoglyphous
Dry Bite Rate
~20% - 30%

Species Bio-Profile & Morphology

Vipera berus (the common European adder or viper) is the most widely distributed venomous snake species in the world, extending from Western Europe to the Russian Far East. Recognized by its distinctive dark zig-zag dorsal pattern, V- or X-shaped marking on the head, and vertical slit-like pupils.

Physical Dimensions

Adults usually average 50–70 cm in total length. Females are larger and heavier than males. Melanic (all-black) specimens occur frequently in cooler northern biomes.

Habitat Preferences

Thrives in diverse environments including chalk downs, heathlands, moorlands, sunny forest glades, and rocky hillsides. Highly dependent on basking microhabitats.

Key Diagnostic Traits vs Non-Venomous Colubrids (e.g. Grass Snake)

Feature Adder (Vipera berus) Grass Snake (Natrix natrix)
Pupil Shape Vertical Slit Round
Dorsal Pattern Dark Zig-Zag Chain Bars / Spots or Uniform
Head Collar Dark V or X shape Yellow / White collar ring
Fang Mechanics Hollow Solenoglyphous Fangs Aglyphous (No fangs)

Solenoglyphous Mechanism

Interactive SVG

Click different anatomical regions of the viper jaw to inspect the venom delivery apparatus.

Venom Gland Hollow Tip
Tubular Solenoglyphous Fang

Vipers possess the most advanced venom delivery mechanism among reptiles. Fangs are long, hollow needle-like teeth mounted on a rotating maxilla bone, folding back against the roof of the mouth when closed.

Enzymatic Composition Breakdown

Percentage dry weight distribution of major protein families in V. berus venom.

65% - 75% Mass

Phospholipase A2 (PLA₂)

Primary enzymatic component causing disruption of cell membrane phospholipids. Induces neurotoxicity, muscle necrosis, hemolysis, and systemic inflammatory cascade. Triggers pro-inflammatory prostaglandin synthesis.

12% - 18% Mass

Snake Venom Metalloproteinases (SVMP)

Degrades basement membrane components and endothelial extracellular matrix. Leads to severe capillary leak syndrome, microvascular damage, local tissue hemorrhage, edema, and ecchymosis.

8% - 12% Mass

Serine Proteases (SVSP)

Interferes with blood coagulation factors. Cleaves fibrinogen into unstable fibrin clots, causing procoagulant consumption coagulopathy and secondary bleeding disorders.

3% - 5% Mass

Hyaluronidase ("Spreading Factor")

Hydrolyzes hyaluronic acid in the extracellular space. Drastically reduces connective tissue viscosity, accelerating the systemic dispersion of other toxins through lymph nodes and capillaries.

Envenomation Cascade Flowchart

STAGE 1 Subcutaneous Inoculation

10-15mm solenoglyphous fang penetration delivers 5–25 mg crude venom payload.

STAGE 2 Enzymatic Tissue Degradation

Hyaluronidase breaks matrix barrier; SVMP hydrolyzes capillary basement membrane.

STAGE 3 Systemic Absorption

Venom enters lymphatic circulation, reaching thoracic duct and blood plasma.

STAGE 4 Clinical Manifestation

Hypotension, gastrointestinal distress, angioedema, renal strain, consumptive coagulopathy.

Resintox Clinical Severity Scale (Grade 0 - Grade 3)

Grade 0 // Dry Bite

No Envenomation

Fang puncture marks present. Minor local pain and mechanical puncture mark irritation without swelling or erythema. No systemic symptoms.

Grade 1 // Mild

Local Reaction Only

Local swelling and edema restricted to the bite location (e.g. hand, foot). Minor ecchymosis around puncture site. Minimal systemic involvement.

Grade 2 // Moderate

Regional / Moderate Systemic

Edema extending beyond entire bitten limb (e.g., reaching trunk). Nausea, vomiting, diarrhea, abdominal cramps, mild hypotension, mild angioedema.

Grade 3 // Severe

Severe Systemic Toxicosis

Widespread swelling crossing trunk lines. Refractory hypotension, circulatory shock, bronchospasm, peripheral hemolysis, acute kidney injury (AKI).

Clinical Symptom Progression Timeline

Average onset window of physiological reactions post-bite in Grade 2-3 envenomations.

Recommended First Aid (DO)

  • Keep Patient Calm & Immobilized: Movement accelerates lymphatic venom uptake through skeletal muscle activity.
  • Remove Rings, Watches & Tight Clothing: Rapid onset edema can quickly cause compartment syndrome or localized ischemia.
  • Immobilize Bitten Limb at Heart Level: Apply a loose splint and keep limb level to slow lymphatic flow without restricting arterial supply.
  • Transport Immediately to Emergency Dept: Monitor baseline vitals, blood pressure, and mark swelling margins every 30 minutes.

Dangerous Contraindications (DON'T)

  • DO NOT Apply Tourniquets: Concentrates digestive proteolytic enzymes, causing severe localized necrosis and loss of limb.
  • DO NOT Cut or Suck the Wound: Introduces bacterial infections; oral suction delivers zero venom reduction while contaminating tissues.
  • DO NOT Apply Ice Packs: Cold aggregation exacerbates microvascular ischemia and tissue damage caused by metalloproteinases.
  • DO NOT Administer NSAIDs / Aspirin: Anti-coagulative properties exacerbate venom-induced coagulopathy and internal bleeding risk.

Antivenom Administration Protocol (e.g., ViperaTox / ViperaTect)

Equine F(ab')2 or Fab fragment antivenoms are indicated for Grade 2 and Grade 3 envenomations, or rapidly progressive Grade 1 edema in pediatric patients.

Indication Threshold Grade 2 or Higher

Persistent hypotension, facial swelling, or edema spreading past major joints.

Infusion Route IV Drip in Normal Saline

Diluted in 100-250 ml 0.9% NaCl over 30–60 minutes. Have epinephrine ready for anaphylaxis.

Pediatric Dosage Note Full Adult Dose

Venom load is identical regardless of patient size; children receive full vial quantities.

Venom Toxicity & Envenomation Risk Calculator

Adjust clinical variables to estimate toxin load (mg/kg) and predicted Resintox severity grade.

60 cm
30cm (Juvenile) 60cm (Avg Adult) 85cm (Trophy Female)
70 kg
10kg (Toddler) 35kg (Child) 70kg (Adult) 120kg
2.0 Hours
15 mins 2 hrs 12 hrs 24 hrs
Calculated Toxin Metrics
Est. Injected Venom 12.5 mg
Relative Mass Load 0.18 mg/kg
Predicted Envenomation Level: GRADE 2 (MODERATE)
Clinical Status: High probability of systemic toxicity due to body mass ratio. Monitor for hypotension, intestinal colic, and swelling crossing knee/elbow. Antivenom evaluation recommended.
*Simulation based on Resintox empirical dose-response matrix.

Thermoregulation & Strike Velocity Predictor

Adders are ectothermic. Ambient temperature directly modulates metabolic rate, muscular strike speed, and defensive reactivity.

22 °C
4°C (Brumation) 20°C (Active) 36°C (Thermal Stress)
Metabolic Output: 82%
Est. Strike Speed: 2.4 m/s
Behavioral State: Basking / Alert

Monthly Adder Bite Frequency & Thermal Correlation